tradingkey.logo
tradingkey.logo
検索

GeneDx Holdings Corp

WGS
ウォッチリストに追加
71.710USD
+3.060+4.46%
終値 07/01, 16:00ET15分遅れの株価
2.13B時価総額
損失額直近12ヶ月PER

詳細情報 GeneDx Holdings Corp 企業名

GeneDx Holdings Corp. is a genomics company. The Company operates, through its subsidiary, GeneDx, LLC, which is focused on exome and genome tests that translate complex genomic data into clinical answers that unlock personalized health plans, accelerate drug discovery, and improve health system efficiencies. It operates through GeneDx segment, which primarily provides pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing and, to a lesser extent, data and information services. Exome sequencing test options include XomeDx, XomeDx Plus, and XomeDxXpress. GeneDx genome sequencing evaluates the protein-coding and non-coding regions of an individual’s nuclear genome. GeneDx genome sequencing test options include GenomeSeqDx and GenomeXpress. It offers a menu of targeted variant testing options to meet the needs of families and healthcare providers. Its subsidiary, Fabric Genomics, Inc., specializes in artificial intelligence-powered genomic interpretation.

GeneDx Holdings Corpの企業情報

企業コードWGS
会社名GeneDx Holdings Corp
上場日Sep 04, 2020
最高経営責任者「CEO」Stueland (Katherine A)
従業員数1000
証券種類Ordinary Share
決算期末Sep 04
本社所在地333 Ludlow Street
都市STAMFORD
証券取引所NASDAQ OMX - NASDAQ BASIC
United States of America
郵便番号06902
電話番号18887291206
ウェブサイトhttps://sema4.com/
企業コードWGS
上場日Sep 04, 2020
最高経営責任者「CEO」Stueland (Katherine A)

GeneDx Holdings Corpの経営陣

会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Joshua Ruch
Mr. Joshua Ruch
Independent Director
Independent Director
185.99K
-20.43%
Mr. Kevin Feeley
Mr. Kevin Feeley
Chief Financial Officer
Chief Financial Officer
39.95K
+12.54%
Dr. Emily M. Leproust, Ph.D.
Dr. Emily M. Leproust, Ph.D.
Independent Director
Independent Director
26.33K
-25.95%
Mr. Keith A. Meister
Mr. Keith A. Meister
Independent Director
Independent Director
20.13K
--
Mr. Jason Michael Ryan, CPA
Mr. Jason Michael Ryan, CPA
Chairman of the Board
Chairman of the Board
--
--
Mr. Eli D. Casdin
Mr. Eli D. Casdin
Independent Director
Independent Director
--
--
Mr. Richard C. (Rick) Pfenniger, Jr.
Mr. Richard C. (Rick) Pfenniger, Jr.
Independent Director
Independent Director
--
--
Ms. Katherine A. Stueland
Ms. Katherine A. Stueland
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Dr. Bryan Dechairo
Dr. Bryan Dechairo
Chief Operating Officer
Chief Operating Officer
--
--
Dr. Thomas Fuchs
Dr. Thomas Fuchs
Director
Director
--
--
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Joshua Ruch
Mr. Joshua Ruch
Independent Director
Independent Director
185.99K
-20.43%
Mr. Kevin Feeley
Mr. Kevin Feeley
Chief Financial Officer
Chief Financial Officer
39.95K
+12.54%
Dr. Emily M. Leproust, Ph.D.
Dr. Emily M. Leproust, Ph.D.
Independent Director
Independent Director
26.33K
-25.95%
Mr. Keith A. Meister
Mr. Keith A. Meister
Independent Director
Independent Director
20.13K
--
Mr. Jason Michael Ryan, CPA
Mr. Jason Michael Ryan, CPA
Chairman of the Board
Chairman of the Board
--
--
Mr. Eli D. Casdin
Mr. Eli D. Casdin
Independent Director
Independent Director
--
--

よくある質問

GeneDx Holdings Corpの上位5名の株主は誰ですか?

GeneDx Holdings Corpの上位5名の株主は以下のとおりです。Mr. Joshua Ruch

GeneDx Holdings Corpの最大の収益源は何ですか?

2026Q4において、Patients with third party insurance部門がGeneDx Holdings Corpにとって最大の収益を生み出しており、その金額は345.24Mで、全収益の80.75%を占めています。